Differential Effects of Punicic Acid on Cytotoxicity and Peroxiredoxin Expression in MCF-7 Breast Cancer and MCF-10A Normal Cells
Anticancer Research · 2024-11 · 44 (11) · 4751-4759
DOI: 10.21873/anticanres.17301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.10.2024. Verfasst von Braden Quitmeyer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Fairfield University, Fairfield, CT, U.S.A. Hauptthemen laut MEDLINE: Peroxiredoxins, Linolenic Acids, Breast Neoplasms, Apoptosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Fairfield University, Fairfield, CT, U.S.A.
- Univerisity of New England College of Osteopathic Medicine, Biddeford, ME, U.S.A.
- Meharry Medical College, Nashville, TN, U.S.A.
- Department of Biology, Fairfield University, Fairfield, CT, U.S.A.; sphelan@fairfield.edu.
Zitieren
APA
Quitmeyer, B., Emelife, C., Klausner, H., Gbayisomore, O., & Phelan, S. (2024). Differential Effects of Punicic Acid on Cytotoxicity and Peroxiredoxin Expression in MCF-7 Breast Cancer and MCF-10A Normal Cells. Anticancer Research, 44(11), 4751-4759. https://doi.org/10.21873/anticanres.17301
Vancouver
Quitmeyer B, Emelife C, Klausner H, Gbayisomore O, Phelan S. Differential Effects of Punicic Acid on Cytotoxicity and Peroxiredoxin Expression in MCF-7 Breast Cancer and MCF-10A Normal Cells. Anticancer Research. 2024;44(11):4751-4759. doi:10.21873/anticanres.17301
BibTeX
@article{Quitmeyer2024,
author = {Quitmeyer, Braden and Emelife, Chiemelie and Klausner, Hannah and Gbayisomore, Oluwafemi and Phelan, Shelley},
title = {Differential Effects of Punicic Acid on Cytotoxicity and Peroxiredoxin Expression in MCF-7 Breast Cancer and MCF-10A Normal Cells},
journal = {Anticancer Research},
year = {2024},
volume = {44},
number = {11},
pages = {4751--4759},
doi = {10.21873/anticanres.17301}
}
EUVIMED